Navigation Links
Valensa International's Dr. Rudi E. Moerck Appointed CEO
Date:2/19/2009

Pharmaceutical Industry Veteran Will Lead Company in Development of 'Next Generation' Dietary Supplements and Functional Food Ingredients

ORLANDO, Fla., Feb. 19 /PRNewswire/ -- Valensa International has appointed Dr. Rudi E. Moerck as President & Chief Executive Officer of the company. The move to add CEO duties for Dr. Moerck comes on the heels of Valensa's partnership with Parry Nutraceuticals (Division of E.I.D. Parry (India) Ltd, Chennai, India) announced last November. In a career that spans more than 25 years, Dr. Moerck has held senior management positions in the pharmaceutical and specialty chemical industries, as well as research and commercial development positions. In his new role, Dr. Moerck will lead Valensa's move into the next generation of high-performance plant-derived dietary supplements and functional food ingredients, which includes Valensa's "Direct to Marketers" product development and business strategy. He will lead Valensa's new management team that includes executives from both Valensa and Parry.

According to Dr. Moerck, the market opportunities for dietary supplements and functional food ingredients are greater than they have ever been. "Health and well-being have become lifestyle decisions for a rapidly growing population segment in the United States and worldwide. A focus on staying healthy and preventing the chronic illnesses that have become so common in our society is a part of emerging healthcare strategies. Simultaneously, the desire for natural products is still increasing throughout all age, income and gender demographics," he said. "We feel that our strategy at Valensa -- to use the most scientifically important natural materials, to use the best technology and quality control, to optimize the product forms in terms of stability and efficacy, and to create compelling messages around our products -- will position us as a 'next generation' leader to the industry and the consumer."

In his previous two years as President, Moerck positioned Valensa as the industry's leading US-based astaxanthin oleoresin and beadlet producer. Moerck also spearheaded Valensa's technology development effort aimed at increasing the bioavailability and efficacy of natural compounds via extraction optimization, dispersion and stabilization technologies and through optimized synergistic ingredient combinations. Under Moerck, Valensa also expanded their intellectual property position with US Patents for USPlus(R) saw palmetto prostate formulas, including Certified Organic USPlus(R), and Zanthin(R) astaxanthin for use in eye health.

Prior to joining Valensa, Dr. Moerck was President of Altair Nanotechnologies. While at Altair, he was the principal inventor of RenaZorb(TM). RenaZorb(TM) was in-licensed by Spectrum Pharmaceuticals (Irvine, CA) in January 2005. While at Altair, he was also the chief innovator of a new drug delivery system called TiNano Spheres(TM) for enhanced and timed release of pharmaceuticals. His work in the pharmaceutical industry includes postings at Catalytica Pharmaceuticals as Sr. Vice President Sales and Marketing, V.P. and General Manager API manufacturing and R&D. He also served as President of the Fine Chemicals and Pharmaceuticals Group at Cambrex Corporation.

    For further information, contact:

    Dr. Rudi E. Moerck, President and CEO
    Voice: 210-632-0695
    Fax: 352-483-2095

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Valensa International
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Valensa International and Parry Nutraceuticals Join Forces in the Global Natural Products Marketplace
2. Valensa and Parry Nutraceuticals Introduce Organic SpiruZan(TM) Spirulina/Astaxanthin Complex as Lifestyle Support for a Fast-Paced World
3. Margaret Laub Appointed to IntelliDOT Board of Directors
4. Laurence Debroux Appointed Chief Strategic Officer (CSO)
5. Jean-Pierre Lehner Appointed Chief Medical Officer
6. Alice Stollenwerk Petrulis, MD, FACP, Appointed to NQF Care Coordination Committee
7. Former Assistant Secretary for Aging, The Honorable Josefina G. Carbonell, Appointed Senior Vice President at Independent Living Systems
8. Perrigo Company Appointed Generic Distributor by Medimetriks Pharmaceuticals
9. Asthma & Allergy Foundation CEO Appointed to NIH Council
10. Ad de Waard Appointed Vice President of International Sales and Marketing at Accumetrics, Inc.
11. Latino Psychologist Appointed to Mental Health Post in Commonwealth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... Abilene, Texas (PRWEB) , ... October 13, 2017 , ... ... publication this week that explains one of the most popular and least understood books ... seems like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have ...
(Date:10/13/2017)... ... 13, 2017 , ... Coveros, a leader in agile coaching ... contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile ... of Agile methodologies in a consistent and high value manner across CMS programs. ...
(Date:10/13/2017)... ... 2017 , ... “America On The Brink”: the Christian history of the United ... the creation of published author, William Nowers. Captain Nowers and his wife, Millie, ... spent thirty years in the Navy. Following his career as a naval aviator ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... Mass. , Oct. 4, 2017 ... of single-use, self-contained, illuminating medical devices, today announced ... National Health Surveillance Agency (or Agência Nacional de ... The first single-use, cordless surgical retractor with integrated ... provides optimal access, illumination and exposure of a ...
(Date:10/2/2017)... 2017  AllianceRx Walgreens Prime, the combined central specialty ... pharmacy benefit manager Prime Therapeutics LLC (Prime), today officially ... the unveiling of new signage at its headquarters in ... at a few other company-owned facilities across the country. ... some of whom will begin to see the AllianceRx ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, Inc. ... earnings conference call and webcast on Friday, November 3, ... (EDT) and ending at approximately 8:30 a.m. (CDT) / ... the company,s 2017 financial performance and guidance for 2018, ... initiatives to enhance operational performance, and long-range financial outlook ...
Breaking Medicine Technology: